Irish fertility intelligence startup Fertally secures €100,000 Enterprise Ireland backing
Founded after CEO Aisling Mooney's 15-year infertility journey, Fertally is building a platform designed to connect fertility care with the latest scientific evidence.
Irish fertility technology startup Fertally has secured €100,000 in funding from the Enterprise Ireland Pre-Seed Start Fund, as it looks to expand clinical pilots and advance development of its evidence-based fertility intelligence platform.
Founded by Aisling Mooney, Fertally is developing a clinical intelligence platform designed to help fertility specialists make more informed treatment decisions by combining real-time patient data with insights drawn from peer-reviewed fertility research.
The platform brings together biomarker data, patient-reported symptoms and clinical outcomes, creating a continuous view of a patient’s fertility journey. This information is then indexed against a growing database of scientific literature, with the aim of helping clinicians identify relevant evidence and treatment approaches more efficiently.
“My aim is to help people facing infertility shorten their journey to growing their families by connecting the dots in a very fragmented system through machine-learning intelligence,” said founder Aisling Mooney.
The funding will be used to expand Fertally’s pilot programme with fertility clinics, support clinical validation of the platform, strengthen its data and regulatory infrastructure, and fund key early hires.
Connecting to the latest evidence
Aisling’s own experience of infertility helped inspire the company.
“After 15 years of infertility, I undertook my own search into medical journals and learned how to decipher trial data and found an article discussing a trial that doctors hadn’t heard of,” she said.
“I found a doctor willing to try the protocol and and it worked on the first cycle. Something clicked when I saw my first positive pregnancy test and I knew I had to find a way to share what I'd found.”
Aisling later began studying programming and machine learning, with the goal of building a platform that could help other people facing infertility navigate what she describes as a fragmented fertility ecosystem.
Fertally operates on a dual model, offering a platform for fertility clinics and clinicians alongside direct research access for patients. The company says it has been designed to GDPR standards and is being developed in line with the EU Medical Device Regulation (MDR) pathway.
The investment comes as fertility providers increasingly explore how data, artificial intelligence and clinical decision-support tools can help personalise treatment and improve patient outcomes.